Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Olfactory Receptors: Location and Structure01:03

Olfactory Receptors: Location and Structure

10.6K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
10.6K
Olfaction01:25

Olfaction

47.1K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
47.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

763
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
763
Physiology of Smell and Olfactory Pathway01:20

Physiology of Smell and Olfactory Pathway

11.1K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
11.1K
Neural Regulation01:37

Neural Regulation

42.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haplotype-resolved long-read sequencing reveals parent-of-origin effects of tandem-repeat variation in autism spectrum disorder.

Science bulletin·2026
Same author

The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohort.

NPJ Parkinson's disease·2026
Same author

Large-scale profiling of blood microbial signatures in patients with Parkinson's disease and its association with disease progression: a cross-sectional study.

EBioMedicine·2026
Same author

Shared genetic architecture between sleep traits and cardiometabolic diseases.

EBioMedicine·2026
Same author

Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson's disease: a randomized phase 2 trial.

Signal transduction and targeted therapy·2026
Same author

Short tandem repeat expansions in patients with neurodegenerative dementia.

EBioMedicine·2026

Related Experiment Video

Updated: Nov 23, 2025

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

22.4K

Olfactory Dysfunction Predicts Disease Progression in Parkinson's Disease: A Longitudinal Study.

Runcheng He1, Yuwen Zhao1, Yan He1

  • 1Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Neuroscience
|December 31, 2020
PubMed
Summary

Olfactory dysfunction, or hyposmia, in Parkinson's disease (PD) patients predicts a worse clinical course. This study shows hyposmia is a useful predictor of PD progression, impacting motor and cognitive symptoms.

Keywords:
Parkinson’s diseasecognitive impairmentdisease progressionhyposmiaolfactory dysfunction

More Related Videos

A Free-breathing fMRI Method to Study Human Olfactory Function
10:42

A Free-breathing fMRI Method to Study Human Olfactory Function

Published on: July 30, 2017

9.9K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.1K

Related Experiment Videos

Last Updated: Nov 23, 2025

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

22.4K
A Free-breathing fMRI Method to Study Human Olfactory Function
10:42

A Free-breathing fMRI Method to Study Human Olfactory Function

Published on: July 30, 2017

9.9K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.1K

Area of Science:

  • Neurology
  • Neuroscience
  • Gerontology

Background:

  • Olfactory dysfunction (hyposmia) is a recognized non-motor symptom in Parkinson's disease (PD).
  • The prognostic value of hyposmia in predicting PD progression remains an area of active investigation.
  • Understanding the link between olfactory function and disease trajectory is crucial for patient management.

Purpose of the Study:

  • To prospectively evaluate the prognostic significance of hyposmia in Parkinson's disease.
  • To compare the clinical manifestations and longitudinal disease progression between hyposmic and normosmic PD patients.
  • To determine if olfactory dysfunction can serve as a marker for PD progression.

Main Methods:

  • Prospective cohort study involving 105 hyposmic and 59 normosmic PD patients over 2 years.
  • Olfactory function assessed using the Sniffin' Sticks test at baseline.
  • Neurological (UPDRS) and neuropsychological (MMSE) assessments conducted at baseline and follow-up.

Main Results:

  • Hyposmic PD patients showed similar baseline characteristics to normosmic patients.
  • At follow-up, hyposmic patients had higher UPDRS II-III scores, greater LED needs, and lower MMSE scores.
  • Hyposmia correlated with increased LED requirements, UPDRS III improvement, and MMSE decline, with poorer odor identification linked to these changes.

Conclusions:

  • Hyposmic PD patients experience a more severe clinical course compared to normosmic counterparts.
  • Olfactory dysfunction is a valuable predictor of Parkinson's disease progression.
  • Hyposmia may indicate a faster or more complex disease trajectory in PD.